The FinTech revolution is not lost. Its outlines may be obscured by the fog of events, but, as this week's links show, it's still moving forward.
Editor's Note: The next issue of FinTech Rising will be published on June 29, ahead of the July 4 holidays in the United States.
This week's report focuses on some of my long-time favorite sources of banking and FinTech news and insight. I follow the industry through reports from media organizations and industry experts I respect and trust. I started thinking about my sources and methods after reading Ron Shevlin's post "FinTech influencer lists have jumped the shark."
"The Mystical Millennials are overly romanticized," said Vic Pascucci, managing partner at VC firm Lightbank. Panelists at Morningstar's New York FinTech Forum, agreed that FinTech services are overly focused on Millennials, with a tendency to focus on FinTech products over consumer experience.
Recent research bears them out.
Last October, mulling over the economic environment the next President would face, I sent Hillary Clinton memos on how she should provide some stimulus to sustain the current expansion and raise incomes by boosting business investment and productivity. Alas, she did not become President; but that didn’t change our current economic challenges. To be sure, President Trump’s manifold troubles may preclude Congress from doing anything meaningful until after the 2018 elections. But if that’s not the case, here’s some advice for both sides.
Co-authored with Wyatt Ritchie, a senior banker focusing on Post-Acute Care and Outsourced Services.
Nature thrives on symbiosis. Its many ecosystems would not exist without important relationships between sometimes strange bedfellows. The oceans’ most colorful coral reefs, for example, are often found in clear water relatively devoid of nutrients.
Co-authored with Gaurov Dayal and Jeff Smith of Lumeris.
In an ideal state, a well-functioning healthcare delivery system should provide the right care at the right time and the right place, while being accountable for clinical and financial outcomes.